Deep Analysis of Impact of COVID-19 on “Glucose Biosensor Market 2012-2022” Growth Worldwide….
Global Glucose
Biosensor Market size is expected
to reach USD 31.0 billion by 2022,
according to a new report by Grand View Research Inc. The global market is
anticipated to witness lucrative growth during the period of 2015 to 2022.
The most common concern for the governments of
all Covid-19 hit nations is the excruciating need to screen for and test large
numbers of patients for possible Sars-Cov-2 infection. As a result, most of
them are facing major shortages in the supply for diagnostic kits to test for
the virus. Diagnostics virology entities are under immense pressure to provide
reliable testing kits, and there is a surge in demand for in-vitro or
point-of-care testing capacities by labs across a large number of countries.
The report will account for Covid19 as a key market contributor.
Some key factors attributing to the
growth of this market include the increasing incidence of diabetes across the
globe, development of technologically advanced products, growing demand for
minimally and non-invasive products, patient awareness levels, and the need for
early diabetes detection. However, presence of other alternatives for
management of the diabetes, such as laboratory methods is expected to restrict
market growth.
The glucose biosensors industry by
end-use is segmented on the basis of its use in hospitals, homecare
diagnostics, and others including research institutes, diagnostics, and
clinical laboratories. The homecare diagnostics market is projected to flourish
over the forecast period. Ease-of-use, quick results, and low costs of the
tests are some aspects supporting market growth. On the other hand, the
hospital-based market is projected to grow at a significant CAGR of 10.3%
during the period 2015 to 2022.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·
North America led the market,
in terms of value, with a share of about 37% in 2015. High disease burden and
the subsequent need to curb associated healthcare expenditure in the U.S., has
resulted in this country account for a large revenue share of the North
American market in 2014. According to the Centers of Disease Control (CDC),
around 22.3 million people in the U.S. were estimated to be diagnosed with
diabetes in the year 2013.
·
Asia Pacific is anticipated to
witness lucrative growth during the forecast period. This market is projected
to grow rapidly during the period 2015 to 2022. China and India are expected to
spearhead market growth in this region.
·
The homecare diagnostics
Glucose Biosensors Market was the largest in 2014. The segment is anticipated
to grow at a rapid CAGR during the forecast period. As of 2015, the market was
led by North America owing to the region's highest disease burden and homecare
diagnostics adoption rates.
·
The market comprises
several local as well as global players. Some major players of this industry
include Roche, Bayer and LifeScan, Inc..
The
global glucose biosensor market was estimated at USD 15.3 billion in 2015.
Increasing incidence of diabetes across the globe is expected to be a key
factor driving market growth. Diabetes is one of the most commonly occurring
diseases worldwide. It is expected to be one of the leading causes of mortality
all over the world.
Rising
prevalence of diabetes globally is a major factor attributing towards the
growth of this market. Blood glucose monitoring is being used as a necessary
tool in diabetes management. As maintenance of normal blood glucose levels is
important for the patients suffering from diabetes, a series of apt glucose
biosensors have been developed to meet the needs of the patients suffering from
this highly prevalent disorder. Furthermore, the growing demand for
self-monitoring devices has augmented the use of biosensors, especially in
portable forms. Glucose sensors are now available as small and minimally
invasive devices that measure glucose levels even in outpatient settings.
Monitoring
of blood glucose level at regular intervals is one of the key factors required
for disease management. Owing to this fact, several technical improvements have
been carried out in the development of sensors. However, development of
reliable and accurate glucose biosensors is still a challenge for market
participants.
The
introduction of technological advancements is expected to play an integral role
in boosting usage rates. This is evident from the development of minimal and
non-invasive glucose biosensors in the market. Several companies, including
small and major, players are involved in extensive R&D initiatives to
develop less painful, cost-effective, more accurate, and reliable
products.
For
instance, NovioSense, a glucose sensor manufacturing company in the
Netherlands, has developed a non-invasive sensor to monitor glucose levels in
tears. However, the presence of alternative methods, such as laboratories
tests, for monitoring of glucose levels in the blood are expected to hinder
glucose biosensors market growth over the forecast period.
Have any Query? Ask our Experts:
Grand View Research has segmented the
global Glucose Biosensors Market on the basis of end-user application:
Glucose Biosensors End-use Outlook (Revenue, USD Million,
2012 - 2022)
·
Hospitals
·
Homecare Diagnostics
·
Others
On
the basis of end-user, the market is fragmented into hospitals, homecare
diagnostics, and others. The others section includes research institutes,
clinical, and diagnostic laboratories. Homecare diagnostics market in terms of
value was estimated to account for the largest share of over 46.0% in
2015.
The
homecare diagnostic segment involves the use of point of care devices including
hand-held glucose meters. These devices are portable, easy-to-use,
cost-effective, and yield quick results. Additionally, the application of these
devices reduces frequent visits to the hospitals.
Some key players operating in this
market include Roche, Bayer, LifeScan Inc., and Abbott. In 2014, collectively,
these companies held a market share of more than 70.0%. The companies are
actively involved in new product development, technological advancements,
partnerships, joint ventures, and collaborations, in an attempt to ensure
sustainability and register growth.
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment